Clinical Trials Directory

Trials / Unknown

UnknownNCT05658835

Interest of Molecular Analysis of Cerebral Thrombi in Determining the Prognosis and Etiology of Cerebral Infarction

Status
Unknown
Phase
Study type
Observational
Enrollment
311 (estimated)
Sponsor
Assistance Publique Hopitaux De Marseille · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The MATISSE (Molecular Analysis of Thrombus for Ischemic Stroke prognosis and Etiology) project evaluates the hypothesis that the molecular composition of cerebral thrombus in metabolites, lipids, and proteins conditions the clinical prognosis at 3 months of the infarction and informs on its etiological subtype

Conditions

Interventions

TypeNameDescription
OTHERThrombi and blood analysesThrombi and blood will be collected during thrombectomy

Timeline

Start date
2023-02-08
Primary completion
2024-11-07
Completion
2025-02-28
First posted
2022-12-21
Last updated
2024-01-31

Locations

4 sites across 1 country: France

Source: ClinicalTrials.gov record NCT05658835. Inclusion in this directory is not an endorsement.

Interest of Molecular Analysis of Cerebral Thrombi in Determining the Prognosis and Etiology of Cerebral Infarction (NCT05658835) · Clinical Trials Directory